600252 Stock Overview
Researches, develops, manufactures, and sells pharmaceuticals in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Guangxi Wuzhou Zhongheng Group Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.64 |
| 52 Week High | CN¥3.28 |
| 52 Week Low | CN¥1.87 |
| Beta | 0.33 |
| 11 Month Change | 16.30% |
| 3 Month Change | 15.79% |
| 1 Year Change | -1.86% |
| 33 Year Change | -15.38% |
| 5 Year Change | -10.51% |
| Change since IPO | 359.81% |
Recent News & Updates
There's Reason For Concern Over Guangxi Wuzhou Zhongheng Group Co.,Ltd's (SHSE:600252) Massive 26% Price Jump
Nov 05
Investors Don't See Light At End Of Guangxi Wuzhou Zhongheng Group Co.,Ltd's (SHSE:600252) Tunnel
Jun 19Recent updates
There's Reason For Concern Over Guangxi Wuzhou Zhongheng Group Co.,Ltd's (SHSE:600252) Massive 26% Price Jump
Nov 05Investors Don't See Light At End Of Guangxi Wuzhou Zhongheng Group Co.,Ltd's (SHSE:600252) Tunnel
Jun 19Guangxi Wuzhou Zhongheng GroupLtd (SHSE:600252) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Apr 05Guangxi Wuzhou Zhongheng GroupLtd (SHSE:600252) Has Debt But No Earnings; Should You Worry?
Mar 15Shareholder Returns
| 600252 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.5% | -6.0% | -6.7% |
| 1Y | -1.9% | -7.9% | 1.9% |
Return vs Industry: 600252 exceeded the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 600252 underperformed the CN Market which returned 1.9% over the past year.
Price Volatility
| 600252 volatility | |
|---|---|
| 600252 Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600252 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600252's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,886 | Yidong Ni | www.wz-zhongheng.com |
Guangxi Wuzhou Zhongheng Group Co.,Ltd researches, develops, manufactures, and sells pharmaceuticals in China. The company offers xueshuantong for injection, zhonghua dieda pills, fuyanjing capsules, jieshitong tablets, yanjianning tablets, angong niuhuang pills, shedan chuanbei liquid, and fluorescein sodium injection covers range of therapeutic areas, such as cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other fields. It also provides toothpaste, mouthwash, mouth spray, laundry detergents, laundry beads, shower gels, Shampoos, electric toothbrush, tooth rinser, electric toothpaste, and other series of products under the Tianqi, Tianqi Doll, and Pure Cotton Era brands; and medical instruments, including mask series, protective clothing, isolation eye masks, and forehead thermometers, as well as Chinese herbal medicines.
Guangxi Wuzhou Zhongheng Group Co.,Ltd Fundamentals Summary
| 600252 fundamental statistics | |
|---|---|
| Market cap | CN¥8.79b |
| Earnings (TTM) | -CN¥24.94m |
| Revenue (TTM) | CN¥2.86b |
3.1x
P/S Ratio-352.4x
P/E RatioIs 600252 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600252 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.86b |
| Cost of Revenue | CN¥1.62b |
| Gross Profit | CN¥1.24b |
| Other Expenses | CN¥1.26b |
| Earnings | -CN¥24.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0075 |
| Gross Margin | 43.24% |
| Net Profit Margin | -0.87% |
| Debt/Equity Ratio | 21.3% |
How did 600252 perform over the long term?
See historical performance and comparison